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Abstract
HOW DOES ALTERATION OF AIRWAY RESISTANCE AFFECT DELIVERED
TIDAL VOLUME IN ADULT PATIENTS RECEIVING HIGH-FREQUENCY
OSCILLATORY VENTILATION (HFOV)?
Concerns exist regarding the ability of HFOV to provide the needed lung protective
ventilation for adult patients with ARDS. HFOV is increasingly being used as a lung
protecting ventilation mode even if some of its protective attributes may be lost as the
airway resistance (Raw) increases or decreases. In fact, in cases of shifting air resistance,
HFOV may have caused lung injury. PURPOSE: The purpose of this study was to
investigate the effect of airway resistance on tidal volume (Vt) delivered by HFOV to adult
patients. Also, the study intended to determine direction for volume change when
resistance increases or decreases. METHODS: An in vitro model was used to simulate an
adult passive patient with ARDS using a breathing simulator (Active Servo Lung 5000,
Ingmar Medical, Pittsburgh, PA, USA). Adjustable resistance and compliance for each
lung was used. The resistance levels of 15, 30, 45 (cm H2O/L/sec) were used for upper and
lower Raw and CL was fixed at 40 mL/cm H2O. The ventilator (Sensormedics 3100B)
was set to MAP = 35 cm H2O, to insp-time of 33%, to bias flow =30 L/min, to delta-P of
80, and to 50% oxygen. Vt was recorded (n=3) for each Raw, and the data was collected on
the host computer. Approximately 200-250 breaths of data for each Raw were captured via
the ASL software and then converted to Excel for analysis. An average of 80 breathes
(following the steady Vt level) was used in each analysis. DATA ANALYSIS: The data
analysis was performed with one way ANOVA and with a post hoc Bonferroni test in order
to determine the statistical significance of the delivered Vt with each Raw. A probability of
(p < 0.05) was accepted as statistically significant. RESULTS: The descriptive statistics of
the average delivered Vt with regard to each Raw (15, 30, 45 cm H2O/L/sec) were the
number of experiments (n=3), mean Vt (93.52, 89.09, 85.99 mL), and standard deviations
(SD) (1.38, 1.11, 1.10) respectively. There was an inverse relationship between tidal
volume and airway resistance during HFOV. With all other variables kept constant, higher
resistance caused less volume, whereas lower resistance caused more volume. The oneway ANOVA test showed that there were significant differences between the delivered
tidal volumes. When the post hoc Bonferroni test was used, the data showed significant
differences between airway resistances of 15 cm H2O/L/sec and 30 cm H2O/L/sec and
between 15 cm H2O/L/sec and 45 cm H2O/L/sec. In contrast, no significant differences
were found between airway resistances of 30 cm H2O/L/sec and 45 cm H2O/L/sec.
CONCLUSION: Vt is not constant during HFOV. Airway resistance is one of the
determinants of delivered tidal volume in adults with ARDS during HFOV. Airway
resistance should be an important factor in ventilator management and in clinical
experiments of patients on HFOV. Without a proper Vt measurement device HFOV should
not be used as lung protective ventilation for adult patients with ARDS.

TABLE OF CONTENTS

List of Figures & Tables ...................................................................................... ii
List of Abbreviations .......................................................................................... iii
Chapter
1

Introduction .......................................................................................................... 2
Purpose........................................................................................................... 5
Study Question .............................................................................................. 5
Significance ................................................................................................... 6

2

A Review of the Literature ................................................................................. 7
HFOV Method of Operation ......................................................................... 7
Successful Use of HFOV with Adult Patients .............................................. 8
Vt Measurement Devices ............................................................................ 11
Variables that Influence Vt in HFOV ......................................................... 12
HFOV Vt Stability....................................................................................... 14

3

Research Methods .............................................................................................. 18
Lung Model ................................................................................................. 18
Ventilator ..................................................................................................... 18
Protocol ........................................................................................................ 19
Data Collection ............................................................................................ 19
Data Analysis ............................................................................................... 20

4

Results of the Study ........................................................................................... 22

5

Discussion .......................................................................................................... 24
Limitations of the Study ............................................................................. 26
Future studies ............................................................................................... 27
Conclusion ..................................................................................................... 28
Appendix. A ....................................................................................................... 29
References .......................................................................................................... 33

i

LIST OF FIGURES & TABLES

Page
FIGURE 1 .................................................................................................... 20
FIGURE 2 .................................................................................................... 23
TABLE 1 ..................................................................................................... 22

ii

List of Abbreviations
ARDS (Adult respiratory distress syndrome)
ARDSNet (ARDS Network trial)
ASL 5000 (Active Servo Lung 5000)
BF (Bias flow)
CDP (Continuous distending pressure)
CL (lung Compliance)
CMV (Conventional mechanical ventilation)
Delta-P (Pressure amplitude)
ETT (Endotracheal tube)
f (Frequency)
HFFI (High frequency flow interrupters)
HFJV (High frequency jet ventilation)
HFOV (High frequency oscillatory ventilation)
HFV (High-frequency ventilation)
ICU (Intensive care unit)
IBW (Ideal body weight)
I.D. (Internal diameter)
LPS (Lung protective strategy)
mPaw (Mean airway pressure)
OI (Oxygenation index)
Raw (Airway resistance)
PEEP (Positive end-expiratory pressure)
Vt (Tidal volume)
VILI (Ventilator-induced lung injury)

iii

CHAPTER I
INTRODUCTION
Conventional mechanical ventilation (CMV) is one of the cornerstones of modern
intensive care practices: its invention dramatically reduced intensive care unit (ICU)
patient mortality. Unfortunately, it has been demonstrated that CMV has in many cases
resulted in secondary lung damage caused by barotrauma, atelectrauma, and volutrauma,
or by a combination of these adverse effects (Dreyfuss & Saumon, 1998). The secondary
lung damage is referred to as ventilator-induced lung injury or VILI. VILI has been found
to prompt an inflammatory response which can lead to adult respiratory distress
syndrome (ARDS) (Dos Santos & Slutsky, 2000). The damage caused by VILI and
ARDS can extend to other organs, leading to multi-organ failure (Slutsky & Tremblay,
1998). In a small number of adult patients, pulmonary gas exchange cannot be improved
sufficiently by means of CMV without causing VILI (Imai et al., 2001).

In order to prevent VILI and to decrease the mortality in adult patients diagnosed
with ARDS, a lung protective ventilation strategy has been investigated and suggested
(ARDSNet, 2000). This strategy administers low tidal volume (Vt) with optimal positive
end-expiratory pressure (PEEP) and has been implemented in adults during the ARDS
Network trial (ARDSNet, 2000). ARDSNet recommendations are designed to prevent or
to hold at a certain level the damage in the lung tissue with acceptable blood gas results.
Today, more strategies to prevent lung damage are available within CMV. Some of the
recommended strategies include: recruitment maneuvers, high PEEP level, prone
2

positioning, and pressure-limited ventilation (Cooper, 2004). Unfortunately, it has been
found that not every clinical condition benefits from lung protective strategies delivered
during CMV (Slutsky & Tremblay, 1998). In cases where CMV fails to support patient’s
oxygenation High-frequency ventilation (HFV) has been instituted. HFV is a nonconventional mode of ventilation that is now used in response to many clinical
conditions.

Three basic types of HFV are currently utilized in intensive care units. These
include high frequency oscillatory ventilation (HFOV), high frequency flow interrupters
(HFFI), and high frequency jet ventilation (HFJV) (Soll, 2006). The different forms of
HFV share a common underlying concept: the delivery of breaths at high frequencies and
low tidal volumes, i.e. at volumes lower than anatomic dead space. HFOV, the subject of
the present study, is both a pressure and time-cycled ventilator. Responding to a patient’s
lung mechanics, it can deliver variable tidal volumes. HFOV is similar to other highfrequency ventilators in that it achieves effective oxygenation by the application of a high
mean airway pressure (mPaw), which is also referred to as the continuous distending
pressure (CDP). HFOV, in contrast to other HFV typ`es, is characterized by the
generation of pressure swings with an active expiration mechanism. Ritacca et al. (2003)
have asserted that active expiration results both in improved PaCO2 elimination and in
reduced gas trapping (Ritacca & Stewart, 2003). Currently, HFOV is the most widely
used form of high-frequency ventilation for treating adult patients.
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HFOV first emerged as a rescue strategy for adult patients with ARDS (Ritacca &
Stewart, 2003). During the initial stages of ARDS, refractory hypoxemia develops as
airway resistance and lung compliance deteriorates. As the severity of ARDS increases
and further lung damage causes increased airway resistance and reduced lung
compliance, conventional ventilation is not able to relieve the hypoxemia.

Regardless of the type of ventilation in ARDS patients, any increase or decrease
of airway resistance will change the amount of delivered Vt (Kallet, Campbell, Dicker,
Katz & Mackersie, 2005). If the delivered Vt changes during CMV it can be monitored,
controlled, and treated by the RT in a timely manner that may help to protect the patient’s
lungs. In contrast, the HFOV is unable to monitor the volume delivered to the lungs.
During HFOV any change in the delivered Vt as a result of changes in the patient’s
condition is difficult to detect. This can result in severe adverse effects on the patient’s
lungs. The adverse effects can be described in one of two ways; as a hypoventilation
resulting in hypercarbia, or as an end-inspiratory alveolar overstretching which can
release inflammatory mediators and prompt an inflammatory response that could lead to
multi-organ failure.

As airway resistance changes, the inability to control or monitor the variable Vt
with available HFOV could explain some adverse outcomes of studies that have
compared HFOV to CMV in ARDS adult patients. Theoretically, HFOV achieves
adequate gas exchange by creating tidal volumes smaller than a patient’s dead space
volume (Vd). Findings by Imai et al. (2001) – that HFOV may be a preferable option to
4

deliver lung protection strategy – could be associated to some extent with the
theoretically low Vt delivered by the HFOV and with the ARDSNet findings from CMV.
On the other hand, several investigators have reported controversial results of trials
comparing HFOV with CMV in adult populations with respiratory distress syndrome
(Bollen, Uiterwaal, & Van Vught, 2006). Since there is not enough scientific data on the
effect of airway resistance on the delivered Vt by HFOV to ARDS in adult patients, the
discrepancies between the reported results comparing HFOV and CMV could be related
to the amount of Vt delivered by HFOV.

Purpose:

The purpose of this study was to investigate the effect of airway resistance on
tidal volume delivered by HFOV to adult patients. This study investigated whether
delivered tidal volume increased or decreased in response to airway resistance change.
Furthermore, this study isolated one of the possible causes of the conflicts in results
between several published studies, which examined the advantages and feasibilities of
HFOV use in the adult population.

Study Question:

One research question directed this study: How does alteration in airway
resistance affect delivered tidal volume in adult patients receiving HFOV?
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Significance:

Concerns exist regarding the ability of HFOV to provide the needed lung protective
ventilation for adult patients with ARDS. HFOV is increasingly being used as a lung
protective ventilation mode even if the protective nature may be lost as the airway
resistance (Raw) increases or decreases.

Results of this study will help to guide the clinical application and monitoring of
HFOV in adult patients. This study will play an important role in redirecting the design of
clinical trials comparing HFOV with CMV.
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CHAPTER II
A REVIEW OF LITERATURE
The literature that informed this study focused on a number of areas: how to
operate the HFOV for adult patients, successful use of HFOV in adult populations, the
available devices for Vt measurement, Vt stability, and the variables that influence
HFOV Vt. A literature search was conducted to identify all randomized trials of HFOV
performed on adult patients with ARDS, with or without tidal volume involvement. The
studies and reviews were collected from PubMed and similar health databases using the
search terms high frequency oscillatory ventilation, acute respiratory distress syndrome,
tidal volume, and adult. Very few studies were found that explored the relationship
between delivered Vt and HFOV. Out of those studies conducted on human subjects,
only one focused on adult patients with ARDS. Most of the reviewed studies involved
either in vitro or animal models.

HFOV Method of Operation:

The Sensormedics 3100B (Sensormedics, Loma Linda, CA, USA) ventilator,
which provides HFOV, has been approved by the United States Food and Drug
Administration (FDA) and has been sold in the U.S. since 2001 (Fessler, & Hess, 2007).
It is the only HFOV model in use. Fessler et al. (2007) and Fan & Stewart (2006) both
reported that the best method to manage HFOV for adult patients is to operate on the
following principles. First, it should use a bias flow of heated and humidified gas
supplied across the proximal end of the endotracheal tube (ETT) set at 30–40 L/min.
7

Second, the mPaw at the proximal end of the endotracheal tube should be set at a
relatively high pressure level of 35 – 45 cm H2O. In order to vibrate this pressurized
flowing gas, the HFOV is equipped with a piston driven diaphragm that creates an
oscillatory effect. Third, the frequency should be, in general, set between 3 and 8 Hz. A
power control regulates the force and distance with which the piston moves from
baseline. A portion of this flow is thereby pumped into and out of the patient by the
oscillating piston.

Successful Use of HFOV with Adult Patients:

HFOV is a new, nonconventional mode of mechanical ventilation designed with
the purpose of overcoming the limitations and adverse effects of CMV for adult patients
(Ritacca & Stewart, 2003). HFOV has demonstrated some success in diminishing the

reduction in pulmonary compliance, lung inflammation, and pathological changes of
small airways and alveoli in ARDS patients. Imai et al. (2001) concluded that HFOV may
be a preferable option as a lung protection strategy over CMV.

During the past several years many research studies have examined the various
aspects of HFOV use in neonatal, pediatric populations, but few have centered on adult
populations. After many controlled, randomized trials, HFOV use is now widely accepted
for use in neonatal and pediatric populations. In contrast, adult HFOV use does not share
the same popularity as there are fewer controlled, randomized trials to support it. The
studies done on neonatal and pediatric populations cannot be used to support the use of
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HFOV in adults because of the differences in physiological structures between the
populations.

The review of the literature found several large-scale adult HFOV studies to be
mutually relevant. Mehta et al. (2004) examined the clinical experience of HFOV in
adults in three medical-surgical ICUs in Toronto, Canada from January 1998 to February
2002. The group described the patient characteristics and the needed strategies for
improved outcomes when HFOV was used. Even though HFOV in different study
findings showed promise as a rescue therapy to improve oxygenation in patients not
responding to CMV, Mehta et al. (2004) concluded that the use of HFOV therapy in
adults with ARDS has limited support. They added that the use of HFOV therapy in
adults with ARDS awaits the performance of more thorough trials comparing HFOV to
CMV using low tidal volumes and that more outcome evaluation, such as mortality, is
needed. As the authors themselves point out, the three medical-surgical ICUs used to
collect their study data did not have a standard method of practice for HFOV, which is
certainly a limitation to the study findings.

The findings of Mehta et al. (2004) contradict those of another study published
earlier by Derdak et al. (2002). This latter study evaluated, prospectively, the safety and
efficacy of HFOV compared with CMV on 148 adult patients with ARDS. The initial Vt
used in the CMV group was 6 – 10 ml/kg, which is higher than the ARDSNet-suggested
Vt. Researchers found that there were no significant differences in hemodynamic
variables, oxygenation failure, ventilation failure, barotraumas, or mucus plugging
9

between the treatment groups. There was no significant trend toward improved 30-day
mortality (evaluated as a secondary outcome) in those receiving HFOV as compared with
conventional mechanical ventilation. They concluded that high frequency oscillation is a
safe and effective mode of ventilation for treating ARDS in adults.

In 2005, a multicentre, randomized trial in four intensive care units was conducted
to compare the safety and efficacy of HFOV with CMV for early intervention in adult
patients with ARDS (Bollen et al., 2005). The CMV strategy was aimed at reducing tidal
volumes. In this study a Vt of 8.4 ± 2.0 ml/kg was used. The study did not find significant
differences in efficacy or safety between HFOV and CMV as an early treatment for
ARDS. Further analysis suggested that HFOV better prevented mortality compared to
CMV specifically in patients with a higher baseline oxygenation index (OI).
The Bollen et al. (2005) study’s report of success with HFOV could be related to
certain clinical conditions that have not been fully examined until even more recently. An
example of such helpful qualification is a study conducted in Prague of Czech Republic
that examined the effect of pulmonary ARDS (ARDS-p) and extrapulmonary ARDS
(ARDS-exp) on physiological and clinical parameters (Pachl, Roubik, Waldauf, Fric, &
Zabrodsky, 2006). Thirty ARDS patients were enrolled in the study. HFOV showed
better lung recruitment for the ARDS-exp group as documented by a statistically
significant increase in values of the PaO2/FIO2 index. The authors of this study
suggested that conventional ventilators would be necessary for proper indication of
treatment, due to their ability to measure and monitor lung compliance. HFOV showed
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some advantages when used in ARDS triggered by extrapulmonary diseases, but was
equal to or worse in patients with pulmonary insult.

Vt Measurement Devices:

A major difference between CMV and HFOV is that with CMV in order to
ventilate a patient, an appropriate Vt is chosen according to the patient’s ideal body
weight (IBW), which is determined by the patient’s height and gender. With CMV there
is a Vt control that can be adjusted to guarantee the delivery of a set Vt to the patient. The
3100B HFOV does not have a Vt measurement because it is assumed that it will always
deliver a low Vt. The lack of a measurement device for Vt on HFOV does not however
mean that it is not measurable. There are some external measurement devices that can be
used to determine the Vt delivered by HFOV.

Four devices to measure Vt during HFOV have been tested and proven to be
reliable and accurate in an in vitro study (Hager et al., 2006). These devices include an
ultrasound flow meter, three differential pressure pneumotachometers, a modified Pitot
tube, and an adult hot wire anemometer. These devices are widely utilized in in-vitro
studies to investigate the Vt delivered to patients through HFOV. Hager et al. concluded
that Vt can be measured during HFOV using various devices, but some of the suggested
devices require calibration to the frequency of the HFOV.

The possibility of measuring Vt during HFOV was examined by Scalfaro, Pillow,
Sly, and Cotting (2001). They assessed the suitability of a hot-wire anemometer infant
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monitoring system for measuring flow and Vt proximal to the ETT during HFOV. The
study was done on an in-vitro lung model simulating moderate to severe respiratory
distress. The researchers concluded that the Florian infant hot-wire flow meter and
monitoring system provided reliable measurements of Vt at the airway opening during
high-frequency oscillatory ventilation when employed at frequencies of 8-13 Hz. Scalfaro
et al. recommended that bedside application of Vt measurement with hot-wire flow meter
could improve monitoring of patients receiving high-frequency oscillatory ventilation.

Variables that Influence Vt in HFOV:

Along with the known effect of lung compliance and airway resistance on
delivered Vt with CMV, any change in the pressure and flow delivering the breath or end
expiratory volume will also influence the delivered Vt. In order to research the possible
variables that could influence the Vt delivered with HFOV, scientists have looked at the
ventilator, circuit, and patient variables.

For the ventilator variables, Niederer, Leuthold, Bush, Spahn, and Schmid (1994)
studied lung surrogates and healthy dogs to determine the influence of the HFOV
dynamic properties on the oscillatory volume delivered through the endotracheal tube.
First, the relationship between the Vt of the pump (oscillator) and the delivered volume in
the lung surrogates was analyzed. Then PaCO2 was measured as a function of the
delivered volume in a number of experiments performed with healthy dogs. This study
also recognized that a minimal condition for adequate gas exchange to take place is
having a delivered volume that exceeds the machine-related dead space. One of the study
12

conclusions was to monitor the delivered volume under clinical conditions because Vt
delivery deviates considerably from the tidal volume of the pump, due to the HFOV
dynamic (particularly resonance) effects.

Frequency in both CMV and HFOV is vital element for controlling the PaCO2
levels. Opposite to that in CMV, frequency in HFOV has to be decreased in order to
remove more CO2, which means that there is some effect on Vt. Fessler, Hager, and
Brower (2008) observed thirty adult patients receiving HFOV for the management of
severe ARDS. They assessed the feasibility of using respiratory frequencies of up to 15
Hz during HFOV in patients with ARDS as a means of delivering low Vt. The study
concluded that most adults can maintain adequate gas exchange using HFOV frequencies
above 5 - 6 Hz (the recommended frequency level in adults) (Fessler et al. (2007). They
added that the use of higher frequencies should minimize tidal volume and might thereby
reduce ventilator-associated lung injury. In this research, it is clear that the limitation of a
HFOV ventilator to measure Vt forced the researchers to use other means (PaCO2 and
frequency) to estimate the delivered Vt, which could be affected by other physiological
changes.

Even though HFOV has proven to be a successful rescue ventilation method for
adult patients with ARDS, there is a lack of systematic studies on its ability to deliver the
required lung protecting ventilation. In the adult population, there have been few studies
conducted on humans that investigate the delivered Vt with HFOV. One recent study did
explore how ventilator variables (frequency, pressure amplitude, CDP, I:E ratio, and bias
13

flow) and one patient variable (compliance) affect tidal volume during HFOV (Hager et
al., 2007). Researchers in this study measured the tidal volumes in test lung and adult
patients with ARDS. The study concluded that tidal volume is not consistently small
during HFOV and that frequency is the primary determinant of tidal volume in adults
with ARDS during HFOV with the Sensormedics 3100B. Test lung findings from the
same study suggest that ETT internal diameter is also an important determinant of tidal
volume. The Hager et al. study observed the effect of the ETT’s internal diameter on the
delivered Vt but provided no information on airway resistance.

HFOV Vt Stability:

HFOV is not a volume controlled ventilator. Therefore, the HFOV delivered Vt
may be lower than the dead space volume, but the Vt is not constant. Theoretically, the
active inhalation and exhalation carried out by HFOV will prevent air trapping in the
lungs which could be caused by the rapid respiratory rates used for HFOV. But that
hypothesis does not take into consideration the overtime variation of airways resistance.
Due to the lower viscosity of a helium-oxygen gas mixture, it is used for patients who
have airway resistance complications. The helium-oxygen gas mixture is also used in
studies to assess the affect of airway resistance on the delivered Vt.

Winters, Willing, and Sanfilippo (2000) conducted a small case study series on
five patients with hypoxemic respiratory failure who developed persistent respiratory
acidosis during treatment with HFOV in order to examine the effect of using a heliumoxygen gas mixture on the patients. The authors reported that using a helium-oxygen gas
14

mixture as a substitute for a nitrogen-oxygen gas mixture during HFOV, improves
ventilation levels (PaCO2 removal). Arterial blood gas values (pH, PaCO2, and PaO2)
were compared in those patients, during both gases mixtures. Results revealed an initial
24% decrease in PaCO2 and an ultimate 43% decrease in PaCO2. The authors related the
PaCO2 improvement to improved gas flow properties as well as to increased PaCO2
diffusion resulting from helium's low-mass density. Though this study was conducted on
a very small group (n=5) and was not a randomized trial, it raises a very important
question: is the Vt delivered with HFOV stable?

A 2003 study answered this question. A randomized, crossover trial compared the
effect of using HFOV with a helium-oxygen gas mixture or with an oxygen-nitrogen gas
mixture on gas exchange in a ten swine (4.4 - 5.4 kg) model with acute lung injury (Katz,
Gentile, Craig, Quick, & Cheifetz, 2003). To control the Vt, the continuous distending
pressure (CDP) was kept at 16.8 +/- 0.3 cm H2O and frequency at 10 Hz, and the
oscillation amplitude was adjusted to maintain constant Vt delivery. The Vt was
measured by respiratory inductive Plethysmography, and gas exchange was assessed by
arterial blood-gas analysis after ventilation with each gas mixture. The authors confirmed
that there were no significant differences in PaCO2 or PaO2 between the two gas
mixtures. They concluded that if delivered Vt is constant, the use of a helium-oxygen gas
mixture does not alter gas exchange when compared with oxygen-enriched air.

Before changing the HFOV settings, Katz et al. (2003) delivered larger Vt when
helium-oxygen gas mixture was used. Lesser amplitude was required for the helium15

oxygen gas mixture to deliver the same volume as the oxygen-nitrogen gas mixture.
There was an apparent decrease in the airway resistance with the helium-oxygen gas
mixture. This study provided supporting evidence that when the friction between airway
walls and the gas used with HFOV is reduced, as is the case with the helium-oxygen gas
mixture, more Vt will be delivered to the lung, as can be seen by the level of PaCO2
removal.

The study question, how does alteration in Raw affect delivered Vt in adult
patients receiving HFOV?- focused the review of literature on few related points. The
findings of the literature review were as follow; first, to operate the Sensormedics 3100B
HFOV for adult patients, bias flow, mPaw, and frequency should be set at a level that
would deliver large Vt. Second, in some studies the use of HFOV demonstrated some
success in adult populations. Whereas, other studies indicated that HFOV therapy in
adults with ARDS has limited support. Third, Vt can be measured during HFOV using
various devices, but some of the suggested devices require calibration to the frequency of
the HFOV. Finally, HFOV delivered Vt is not stable and could be influenced by other
variables like; frequency, HFOV dynamic properties, ETT size, lung compliance, and
type of the gas used.

Much of the information on the physiological effects and delivered Vt of highfrequency oscillation has been obtained through animal studies. Few studies have been
conducted on humans. Further investigations are needed to produce outcomes that can
then be used in clinical settings. Delivered tidal volume by HFOV is not constant due to
16

many factors, some of them related to the patient’s condition, and others related to the
ventilator and the type of gas used.
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CHAPTER III
RESEARCH METHODS
Lung Model:
In this study, an-in vitro model was used to simulate an adult passive patient with
ARDS using a breathing simulator, Active Servo Lung (ASL) 5000 (Ingmar Medical,
Pittsburgh, PA, USA). The ASL 5000 was digitally controlled, by software on host
computer and is a piston-driven, real-time breathing simulator generated various types of
breath, including that of a passive patient (Appendix-A).
Ventilator:
This study also used a Sensormedics 3100B (Sensormedics, Loma Linda, CA,
USA) ventilator with a standard HFOV adult circuit and a cuffed endotracheal tube size
8.0 mm internal diameter (I.D.) (Portex, Hythe Kent, England). The 3100B’s HFOV
parameters were set for adult patients with ARDS according to the guidelines in Fessler
et al. (2007). These guidelines were implemented to direct routine clinical care for
clinicians operating HFOV. Researchers in that study recommended the guidelines to
optimize the lung protective characteristics of HFOV. In this study, throughout the
experiment, the 3100B ventilator was run continuously at pressure amplitude (delta-P) of
80 cm H2O, at 33% inspiratory time (I-time), at frequency (f) of 5 Hz, at mean airway
pressure (mPaw) of 35 cm H2O, at bias flow (BF) of 30 L/min, and at 50% oxygen
(Appendix - A).
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Protocol:
In order to mimic adult patients with severe ARDS on HFOV (during which the
patient is fully sedated and immobilized), the ASL 5000 scenario of an adult passive
patient with changeable resistance (Raw) and compliance (CL) was selected for each
lung. The resistances for upper and lower airways were set during the experiment at the
different levels (15, 30, and 45 cm H2O/L/sec) and CL was fixed at 40 mL/cm H2O
(Appendix-A).
The 3100B ventilator was calibrated, and then set to deliver mPaw of 35 cm H2O,
delta-P of 80 cm H2O, at 33% I-time, at f of 5 Hz, at BF of 30 L/min, and at 50% O2.
The ASL 5000 was connected to the ventilator (Figure 1) with a standard high-frequency
breathing circuit and size 8.0 mm I.D. cuffed ETT. The ASL 5000 was connected to the
software host computer via Ethernet cable. Flow and mPaw were measured inside the test
lung and recorded by the software on the host computer. For each level of resistance the
HFOV and ASL 5000 were disconnected, turned off, and then restarted again. (Restarting
the ASL 5000 is the method recommended in the manual for calibration).
Data Collection:
Vt was measured and recorded three times (n = 3) for each level of Raw. The
measurements were taken by ASL 5000 software at the same ventilator settings.
Approximately 200-250 breaths of data for each level of Raw were captured via the ASL
software and then converted to Excel software for analysis. By reviewing the captured
data (Vt waveform on the computer screen), there was a period for the volume to build up
inside the ASL 5000 before a steady state was reached (the Vt waveform is stable with no
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accelerating increase). After a steady state was established, an average Vt for eighty
breaths was recorded and used for the analysis in this study.

Figure 1. Schematic Drawing of the Experimental Set-up.
Data Analysis:
Data was analyzed using SPSS for Windows (Version 15). The data analysis was
performed with one-way ANOVA and a post hoc Bonferroni test to determine the
statistical significance of the delivered Vt with different Raw. A probability of p < 0.05
was accepted as statistically significant.

The research methods were directed by the study question: how does alteration in
Raw affect delivered Vt in adult patients receiving HFOV. Sensormidics 3100B
ventilator, the only adult patients HFOV in use these days, was used. A lung simulator
with the ability to control the Raw, CL, patient size, and measure Vt was used. The
software recorded the information and helped to control data collection at a similar level
20

in all trials. The protocol was aimed to rebate the same conditions during all experiments
and eliminate every possible bias.
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CHAPTER IV
RESULTS OF THE STUDY
Table 1displays the descriptive statistics of the average delivered Vt with each
Raw (15, 30, 45) cm H2O/L/sec used in this study. The table below presents the sample
size, Mean Vt, Minimum Vt (Min. Vt), Maximum Vt (Max. Vt), and Standard Deviation
(SD). The statistics establish that there was an inverse relationship between tidal volume
and airway resistance during HFOV. Specifically, the study found that as the Raw
increases the delivered Vt decreases.

Variable Raw
n

Mean Vt (mL)

SD

Min Vt (mL)

Max Vt (mL)

15

3

93.52

1.38

91.97

94.61

30

3

89.09

1.11

88.26

90.35

45

3

85.99

1.10

85.00

87.17

(cm H2O/L/sec)

Table 1. The Descriptive Statistics of the Average Tidal Volume Delivered at
Each Airway Resistance.

The one-way ANOVA test showed that there was a significant difference between
the airway resistances used in this study. When the post hoc Bonferroni test was used
(Figure 2), the data showed highly statistically significant between airway resistances of
15 cm H2O/L/sec and 30 cm H2O/L/sec and between 15 cm H2O/L/sec and 45 cm
H2O/L/sec (p<0.012 & p<0.001, respectively). However, there was no statistically
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significant, but clinically significant, between an airway resistance of 30 cm H2O/L/sec
and 45 cm H2O/L/sec (p<0.059).

Figure 2. The Mean Delivered Tidal Volume with the Statistically Significant
Differences at Each Level of Airway Resistance.
*p < 0.05, ns = No Statistical Significance.
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CHAPTER V
DISCUSSION
The main focus of this study was to evaluate the influence of Raw on the
delivered Vt in adult patients with ARDS. The study data suggests that, for a given
HFOV setting, any change in airway resistance will have an inverse effect on the
delivered Vt. Other studies have examined the effect of other vital variables including
HFOV frequency mPaw, ETT size, and lung CL on delivered Vt. Each study showed that
its particular variable had a clear effect on delivered Vt, either increasing or decreasing
tidal volume (Fessler, Hager, & Brower, 2008; Hager et al., 2007; Niederer et al., 1994).
Endotracheal tubes have a fixed resistance, and when the size is reduced – from 8 to 7 or
from 7 to 6 mm I.D. – the HFOV Vt will decrease by 15.3% and 18.9%, respectively
(Hager et al., 2007). Our study showed similar trend even though the Raw represents the
patient’s small Raw and it is a dynamic variable. No other study has been conducted to
examine how a changeable Raw (i.e., a patient’s constantly changing airway resistance)
affects Vt.

A reduction in the delivered Vt caused by a sudden decrease in Raw could result
in a reduction in the level of gas exchange, especially when Vt drops below the circuit
dead space volume (Niederer et al., 1994). Lung protective strategy (LPS), as introduced
by ARDSNet (characterized by low Vt with optimal PEEP), is the overall goal for health
care providers treating ventilated patients. The important elements of a lung protective
strategy are recruitment of the lung and minimization of alveolar overstretching. Even if
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HFOV offers the promise of delivering low Vt, it should not be the first choice to provide
the LPS, because there is no assurance for a constant delivered Vt. As discussed in the
literature review, published studies have found that tidal volume is not constantly small
during HFOV (Hager et al., 2007). Our study mainly used ventilator settings similar to
that used by Fessler et al. (2007) protocol. The constant ventilator settings did not provide
the LPS needed for ventilated patients when the Raw changed.

Even though HFOV Vt is less than anatomical dead space volume, some studies
on humans have shown that in certain conditions the Vt can be more than the Vd. The
level of end expiratory volume delivered with HFOV (with a high CDP point) may
enhance the lungs susceptibility to damage if there is a rapid change to the Vt delivered
(e.g., a change in Raw). The results of HFOV studies focusing on Vt could explain the
inconsistent results and outcomes from studies with similar settings which did not take Vt
into consideration (Mehta et al., 2004; Derdak et al., 2002).

In the routine monitoring of patients receiving HFOV, health care clinicians
depend on observations of chest movement, chest radiographs, and trends in PaCO2 level
to make appropriate adjustments. The findings of this study and of similar studies, in
combination with recent developments in medical equipment, indicate that utilizing a Vt
monitor on HFOV is both feasible and necessary. Further, having a Vt monitor could
decrease the cost of frequent arterial blood gases and chest radiographs. A Vt monitor
could also prevent issues that might lead to lung overstretching and its potentially serious
adverse effects on patients.
25

Limitations of the Study:

In any study one can expect limitations that are outside the control of the researcher.
The present study has certain limitations that need to be taken into account when
considering the study and its contributions. The following limitations were recognized by
the researcher as being possible:

1. In an in-vitro study findings are difficult to generalize for the reason of
simulator does not model the actual patient condition.

2. The lung simulator used for the study, according to manufacturer
recommendation, prevented the use of humidification system, which is an
important part when HVOV is used.

3. Leak presence, and the ability to make a proper seal throughout the circuit was
not introduced in the study design, which could explain the deference in the
amount of delivered Vt at different Raw settings.

4. Vt in our study was calculated by the ASL 5000 software due to the lack of
measuring devices that could validate our results.

Although these limiting factors are considered outside the control of the researcher, it is
important to recognize each one in order to effectively evaluate the significance of this
study. These limitations decrease full application in clinical setting. Some of these
limitations can be seen as fruitful opportunity for future research under the same theme.
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Future studies:

Although the observed volume changes in this study may not be exactly what
occur clinically, where each patient is unique, the direction and general amount are most
likely correct. Further investigation is needed on the influence of other factors on
delivered Vt with HFOV. More research is also needed to determine how bronchodilator
administration in HFOV patients affects Vt. More randomized control studies should be
conducted in order to evaluate all of the factors that could affect HFOV-delivered Vt.
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CONCLUSION
The primary focus of this study was to answer the question: how does alteration in
Raw affect delivered Vt in adult patients receiving HFOV? The results of the study
showed inverse relationship between Raw and HFOV delivered Vt. As the Raw changes
the HFOV delivered Vt will change to the opposite direction. The data gathered to
answer research questions helped to address the conclusion of the study.

In conclusion, tidal volume is not constant during high frequency oscillatory
ventilation. Airway resistance is one of the determinants of Vt in adults with ARDS
undergoing HFOV. Raw should be an important factor in ventilator management and
clinical experiments of patients on HFOV.
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APPENDIX
Appendix - A.
Protocol
High-Frequency & Tidal Volume
Goals:
 To determine the delivered tidal volume (Vt) (past ETT).
 To examine the influence of airway resistance on the delivered Vt (n=3 for
each Raw)

Methods:
 For airway resistance 15 cm H2O/L/sec do three trials as follow;
a) Test lung
1. Use ASL 5000 breathing simulator.
2. Connect the simulator ASL 5000 to line power then switch it on.
i. The Motor red light is enabled.
ii. Wait for the Motor red light to turn off.
iii. ASL 5000 is calibrated and ready to be connected to the ventilator
and computer.
3. Connect the ASL 5000 to the host PC via Ethernet networking cable.
4. Connect the ASL 5000 with HFOV through standard high-frequency
breathing circuit and size 8.0 mm I.D. cuffed ETT.

b) Ventilator
1. Use Sensormedics 3100B (Sensormedics, Loma Linda, CA, USA)
(3100B).
2. Calibrate the 3100B ventilator with capped standard high-frequency
breathing circuit;
i. Set bias flow at 30 L/min.
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ii. Mean Airway Pressure (mPaw) to maximum.
iii. Pressure amplitude (delta-P) of 60 cm H2O.
iv. Set inspiratory time (I-time) to 33%.
v. Start the 3100B ventilator wait for the mPaw reading to reach
between 40 & 45 cm H2O.
vi. 3100B ventilator is ready.
3. Set the 3100B ventilator to the following;
i. Delta-P of 80 cm H2O.
ii. Frequency (f) of 5 Hz.
iii. mPaw of 35 cm H2O.
iv. BF of 30 L/min.
v. I-time to 33%.
vi. Oxygen to 50%.
4. Connect the standard high-frequency breathing circuit and size 8.0 mm
I.D. cuffed ETT (Portex, Hythe Kent, England) to the ASL 5000.
5. Go to step (c – 9 – i).

c) Computer
1. After all necessary cable connections have been completed (step a – 3);
launch the LabView software on the host PC.
2. Working page (welcome window) is presented;
i. From welcome window choose ―run the software with Ethernet‖
mode.
ii. Welcome window will disappear and several windows will be
stacking up on computer screen.
iii. Host computer will attempt to synchronize with the ASL 5000.
iv. Wait for ASL 5000 response (simulator piston will move).
3. From the ―Script Editor window‖ chose (Adult_apnea.sct) file to edit
its model parameter files.
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4. From the ―Script File‖ box click two times on the file name
(Adult_apnea.sct).
5. A window titled "Step 1: Select Simulation Parameter Set" will open.
i. Click edit to proceed to the next step.
6. A window titled ―step 2: choose a lung model‖ will open.
i. Chose the two compartment lung model.
ii. Set resistance (Raw1) to 15 cm H2O/L/sec.
iii. Set resistance (Raw2) to 15 cm H2O/L/sec.
iv. Set compliance (CL1) to 20 mL/cm H2O.
v. Set compliance (CL2) to 20 mL/cm H2O.
vi. Click ―next‖.
7. A window titled ―Step 3: Chest Wall Model‖ will open.
i. From chest wall model pop-up menu chose passive model.
ii. Set the passive cycle to 12 breathes per minute.
iii. Click ―next‖.
8. A window titled ―step 4: save simulation parameter set‖ will open.
i. Click ―save‖ to save the new variables in the file.
9. From the ―Central Runtime Window‖ while the ventilator is running
and connected to the ASL 5000;
i. Start the simulation by moving the "slide switch from the ―OFF‖
to the ―ON‖ position.
ii. From file window chose a name for the data file path to store the
data.
iii. Click ―OK‖.
10. Go to ―Breath Detection / Real-Time Analysis‖ window.
i. Check the ―save data to high resolution file‖ checkbox.
ii. Wait for the data of 250 breaths to be collected.
11. Turn off the simulation by moving the "slide switch from the ―ON‖ to
the ―OFF‖ position.
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d) Data Collection
1. Launch the Lab VIEW software on the host computer.
2. Go to ―post-run‖ window.
i. Choose the file to be displayed click it two times.
ii. Open ―multiple parameter trend‖ from the green box under the
―display data‖ list.
3. Check the Vt waveform to establish the steady state.
i. The Vt increases gradually to build up the volume in the test lung.
ii. The steady state is when there is no more increase in the Vt
delivered.
4. Review the volume waveform and select 80 breathes from the
beginning of a steady state.
5. The average tidal volume for the 80 breaths will be displayed.
6. Record the average tidal volume and use it in data analysis.
 For the airway resistance 30 cm H2O/L/sec do three trials as follow;
o Repeat the steps a, b, c, and d, but at steps (c – 6 – ii and iii) change the
airway resistance to 30 cm H2O/L/sec.
 For the airway resistance 45 cm H2O/L/sec do three trials as follow;
o Repeat the steps a, b, c, and d, but at steps (c – 6 – ii and iii) change the
airway resistance to 45 cm H2O/L/sec.
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